Finally, going back to circulating cytokines and mass immunophenotyping of blood cells in PAH patients with KCNK3 mutation, we found that the inflammatory defects were congruent with those found in mice (Figure S3 and Figure 6). Here, KCNK3 is linked to pulmonary arterial hypertension.